 "SPARC gains ahead of board meet for rights issue")
Sun Pharma Advanced Research Company (SPARC) has rallied nearly 8% to Rs 301 on the BSE ahead of the board meet on March 5, 2016 for the proposed rights issue.
The board of directors of the company will be held on March 05, 2016, to fix the issue price, issue size, rights entitlement ratio, fractional entitlement and record date / book closure dates for determining eligibility of the shareholders to whom the equity shares are to be issued under the proposed Rights Issue of the company, SPARC said in a statement.
The company’s board in March 2016 had approved to raise up to Rs 250 crore through rights issue.
At 09:30 AM, the stock was up 6% at Rs 297 on the BSE. A combined 319,709 shares changed hands on the counter on the BSE and NSE so far.
The board of directors of the company will be held on March 05, 2016, to fix the issue price, issue size, rights entitlement ratio, fractional entitlement and record date / book closure dates for determining eligibility of the shareholders to whom the equity shares are to be issued under the proposed Rights Issue of the company, SPARC said in a statement.
The company’s board in March 2016 had approved to raise up to Rs 250 crore through rights issue.
At 09:30 AM, the stock was up 6% at Rs 297 on the BSE. A combined 319,709 shares changed hands on the counter on the BSE and NSE so far.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%